NCT01362621

Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

A 2-year Prospective, Multi-center, Observational and Epidemiologic Outcomes Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 474 (actual)
• Sponsor: Novartis Pharmaceuticals · Industry
• Sex: All
• Age: 6 Years – 11 Years
• Healthy volunteers: Not accepted

Summary

The study was designed to collect data about inadequately controlled moderate to severe allergic asthma in subjects 6 to \< 12 years of age, managed in a real-world setting.

Conditions

• Moderate to Severe Allergic Asthma

Timeline

• Start date: 2008-02-01
• Primary completion: 2010-02-01
• First posted: 2011-05-30
• Last updated: 2011-06-16

Locations

51 sites across 2 countries: United States, Puerto Rico